Engineered nanoparticles as precise drug delivery systems

Journal of Cellular Biochemistry

Volumn 97, Issue 6, 2006, Pages 1184-1190

  Yih, T C ^a   Al Fandi, M ^a  

^a UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

Author keywords

Architecture; Drug delivery; Material; Nanoparticles; Nanotechnology; Therapeutic agent; Therapeutic application

Indexed keywords

CARBON NANOTUBE; DENDRIMER; DRUG CARRIER; LIPOSOME;

DRUG DELIVERY SYSTEM; DRUG TARGETING; IMPLANT; MICELLE; NANOPARTICLE; NANOTECHNOLOGY; PRIORITY JOURNAL; REVIEW;

CERAMICS; DRUG DELIVERY SYSTEMS; LIPOSOMES; NANOSTRUCTURES; NANOTECHNOLOGY; POLYMERS;

EID: 33645691940     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.20796     Document Type: Review

References (51)

1. Al Khouri N, Roblot L, Fessi H, Devissaguet P, Puisieneux F. 1986. Development of a new process for the manufacture of polysiobutylcyanoacrylate nanoencapsules. Int J Pharm 28:125-132.
2. Boas U, Heegaard M. 2004. Dendrimers in drug research. Chem Soc Rev 33(1):43-63.
3. Brigger I, Dubernet C, Couvreur P. 2002. Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631-651.
4. Chen Z, Cooper L. 2002. Interactions between dendrimer biocides and bacterial membranes. Biomat 23(16):3359-3368.
5. Cherian K, Rana C, Jian K. 2000. Self-assembled carbohydrate-stabilized ceramic nanoparticles for parenteral delivery of insulin. Drug Dev Ind Pharm 26(4):459-463.
6. Cohen H, Levy R, Gao J, Fishben I, Kousaev X, Sosnoski S, Slomkowski S. 2000. Sustained delivery and expression of DNA encapsulated in polymeric nanoparticles. Gen Thr 7:1896-1905.
7. Cui Z, Han S, Padinjarae D, Huang L. 2005. Immunostimulation mechanism of LPD nanoparticles as a vaccine carrier. Mol Pharmaceut 2(1):22-28.
8. Davis S, Illum L. 1998. Drug delivery systems challenging molecules. Inter J of Pharm 176:1-8.
9. Dey S. 2005. Inorganic biohybrid nanoparticles for targeted drug delivery. Proc. 6th Anul. Cambridge Health Institute.
10. Goren D, Horowitz T, Zalipsky S, Woodle C, Yarden Y, Gabizon A. 1996. Targeting of Stealth liposomes to erbB-2 (Her/2) receptor: In vitro and in vivo studies. Br J Cancer 74:1749-1756.
11. Guzman L, Labhasetwar V, Song C, Jang Y, Lincoff M, Levy R, Topol E. 1996. Local intraluminal infusion of biodegradable polymeric nanoparticles. A novel approach for prolonged drug delivery after balloon angioplasty. Circulation 94:1441-1448.
12. Herffernan M, Murthy N. 2005. Polyketal nanoparticles: A new pH-sensitive biodegradable drug delivery vehicle. Bioconj Chem ASAP Article.
13. Hobbs K, Monsky W, Yuan F, Roberts W, Griffith L, Torchilin P, Jain R. 1998. Regulation of transport pathways in tumor vessels: Role of tumor type and microenvironment. Proc Natl Acad Sci USA 95:4607-4612.
14. Hofheinz D, Gnad-Vogt U, Beyer U, Hochhaus A. 2005. Liposomal encapsulated anti-cancer drugs. Anticancer Drugs 16(7):691-707.
15. Hughes G. 2005. Nanostructure-mediated drug delivery. Nanomedicine 1(1):22-30.
16. Kataoka K, Harada A, Nagasaki Y. 2001. Block copolymer micelles for drug delivery: Design, characterization and biological significance. Adv Drug Dev Rev 47:113-131.
17. 254: A tumor-targeting therapeutic agent for gadolinium neutron capture therapy of intraperitoneal disseminated tumor which can be monitored by MRI. Bioconjugate Chem 12(4):587-593.
18. Kreuter J, Ramge P, Petrov V, Hamm S, Alyautdin R, Briesen H, Begley D. 2003. Direct evidence that polysorbate-80-coated poly(butylcyanoacrylate) nanoparticles deliver drugs to CNS via specific mechanisms requiring prior binding of drug to the nanoparticles. Pharm Res 20:409-416.
19. Labhasetwar V, Bonado J, Goldstin L. 1999. Gene transfection using biodegradable nanospheres: Results in tissue culture and rat osteotomy model. Coll Surf B: Bioinformatics 16:281-290.
20. Lamprecht A, Ubrich N, Yamamoto H, Schafer U, Takeuchi H, Maincent P, Kawashima Y, Lehr CM. 2001. Biodegradable nanoparticles for targeted delivery in treatment of inflammatory bowl disease. J Pharmacol Exp Ther 299:775-781.
21. Lasic D, Vallner J, Working K. 1999. Sterically stabilized liposomes in cancer therapy and gene delivery. Curr Opin Mol Ther 1(2):177-185.
22. Latallo J, Candido K, Cao Z, Nigavekar S, Majoros I, Thomas T, Baglogh L, Khan M, Baker J. 2005. Nanoparticles targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65(12):5317-5324.
23. Olivier J, Fenart L, Chauvet R, Pariat C, Cecchelli R, Couet W. 1999. Indirect evidence that drug brain targeting using Doxorupolysorbate 80-coated polybutylcyanoacrylate nanoparticles is related to toxicity. Pharm Res 16:1836-1842.
24. Panyam J, Labhasetwar V. 2003. Biodegradable nanoparticles for drug delivery gene delivery to cells and tissue. Adv Drug Deliv Rev 55:329-347.
25. Panyam J, Lof J, O'Leary E, Labhasetwar V. 2002. Efficiency of dispatch and infiltration cardiac infusion catheters in arterial localization of nanoparticles in porcine coronary model restenosis. J Drug Target 10:515-523.
26. Paul W, Sharma C. 2001. Porous hydroxyapatite nanoparticles for intestinal delivery insulin. Trends Biom Artif Organs 14(2):37-38.
27. Plotkin A. 2003. Vaccines, vaccination, and vaccinology. J Infect Dis 187(9):1349-1359.
28. Priyabrata M, Resham B, Debabrata M. 2005. Gold nanoparticles bearing functional anti-cancer drug and anti-angiogenic agent: A "2 in 1" system with potential application in therapeutics. J Biomd Nanotech 1(2):224-228.
29. Quintana A, Raczka E, Piehler L, Lee I, Myc A, Majoros I, Patri A, Thomas T, Mule J, Baker J. 2002. Design and function of a dendrimer-based therapeutic nanodevice targeted to tumor cells through the folate receptor. Phar Res 19(9):1310-1316.
30. Raghuvanshi R, Mistra A, Talwar G, Levy R, Labhasetwar V. 2001. Enhanced immune response with combination of alum and biodegradable nanoparticles containing tetanus toxoid. J Micoencapsul 18:723-732.
31. Rao M, Alving R. 2000. Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. Adv Drug Deliv Rev 41:171-188.
32. Rapoport N, Pitt G, Sun H, Nelson L. 2003. Drug delivery in polymeric micelles: From in vitro to in vivo. J Control Release 91:85-95.
33. Rojo J, Delgado R. 2004. Glycodendritic structures: Promising new antiviral drugs. J Antimicrob Chemo 54(3):579-582.
34. Roy I, Mitra S, Maitra A, Mozumdar S. 2003a. Calcium phosphate nanoparticles as novel non-viral vectors for targeted gene delivery. Int J Pharm 250:25-33.
35. Roy I, Ohulchanskyy T, Pudavar H, Bergey E, Oseroff A, Morgan J, Dougherty T, Prasad P. 2003b. Ceramic-based nanoparticles entrapping water-insoluble photosensitizing anticancer drugs: A novel drug-carrier system for photodynamic therapy. J Am Chem Soc 125:7860-7865.
36. Sahoo S, Labhasetwar V. 2003. Nanotech approaches to drug delivery and image. Res Focus Rev 8(24):1112-1120.
37. Schafer V, Briesen H, Andereesen R, Steffan A, Royer C, Troster S, Kreuter J, Waimann H. 1992. Phagocytosis of nanoparticles by human immunodeficiency virus (HIV)-infected macrograph: A possibility for antiviral drug targeting. Pharm Research 9(4):541-546.
38. Slepushkin A, Salem I, Andreev M, Dazin P, Duzgunes N. 1996. Targeting of liposomes to HIV-1-infected cells by peptides derived from the CD4 receptor. Biochem Biophys Res Commun 227:827-833.
39. Soppimath S, Amminabhavi M, Kulkarni R, Rudzinski E. 2001. Biodegradable polymeric nanoparticles as drug delivery devices. J Contrl Release 70:1-20.
40. Sun Y, Mayers T, Xia Y. 2002. Template-engaged replacement reaction: A one-step approach to large scale synthesis of metal nanostructure with hollow interior. Nano Lett 2:481-485.
41. Unezaki S, Maruyama K, Hosoda J, Nagae I, Koyanagi Y, Nakata M, Ishida O, Iwatsuru M, Tsuchiya S. 1996. Direct measurement of the extravasation of polyethyleneglycol-coated liposomes into solid tumor tissue by in vivo fluorescence microscopy. Int J Pharm 144:11-17.
42. Versluis J, Rump T, Rensen C, Van Berkel J, Bijsterbosch K. 1998. Synthesis of a lipophilic daunorubicin derivative and its incorporation into lipidic carriers developed for LDL receptor mediated tumor therapy. Pharm Res 15:531-537.
43. Wang S, Gao R, Zhou F, Selke M. 2004. Nanomaterials and single oxygen photosensitizers: Potential applications in photodynamic therapy. J Mat Chem 14:487-493.
44. Watnasirichailkul S, Davis M, Rades T, Tucker G. 2000. Preparation of biodegradable insulin nanocapsulates from biocompatible microemulsions. Pharm Res 17:684-689.
45. Witvrouw M, Fikkert V, Pluymers W, Matthews M, Mardel K, Schols K, Raff J, Debyser Z, Clercq E, Holan G, Pannecouque C. 2000. Polyanionic (i.e polysulfonate) dendrimers can inhibit the replication of human immunodeficiency virus by interfering with both virus adsorption and later steps (reverse transcriptase/integrase) in virus replicative cycle. Molecular Pharmacology 58:1100-1108.
46. Yih T, Brunson W, Wordinger J, Hu Z, Chen R. 2002. Development of micro-pump for localized delivery of controlled drug release hydrogel nanoparticles to improve cancer and glaucoma treatment. NanoTech.
47. Yih T. 2005a. Application of nanotechnology to drug delivery systems. Nanomedicine: Nanotech Biol Med 1(3):244-245.
48. Yih T, Wei C. 2005b. Nanomedicine in cancer treatment. Nanomedicine: Nanotech Biol Med 1(2):191-192.
49. Yih T, Wei C, Hammad B. 2005c. Modeling and characterization of nano-liter drug delivery MEMS micropump with circular bossed membrane. Nanomedicine: Nanotech Biol Med 1(2):164-175.
50. Yokoyama M, Miyauchi M, Yamada N, Okano T, Sakurai Y, Kataoka K, Lnoue S. 1990. Polymer micelles as novel drug carrier: Adriamycin-conjugated poly(ethylene glycol)-poly(aspartic acid) block copolymer. J Controlled Release 11:269-278.
51. Yu G, Okano T, Kataoka K, Kwon G. 1998. Polymeric micelles for drug delivery: Solubilization and haemolytic activity of amphotericin B. J Control Release 53:131-136.